Allison Cimler, APRN
Family · Lexington, SCNPI 1871812842
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Johnson & Johnson at 59.3% of the total. Reporting peaked in 2022 at $102 and has fallen 55.0% since, to $46 in 2025. That places this record below the midpoint for family clinicians in SC, where the typical reported total is $407.
Across 8 payments — averaging $26.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$123
- Alpha Cognition USA, Inc.$46
- Merck$26
- Medtronic$13
What the payments were for
- Food & beverage$208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $123 |
| Alpha Cognition USA, Inc. | 1 | $46 |
| Merck | 1 | $26 |
| Medtronic | 1 | $13 |
How this compares
$208 in reported general payments places this provider in the 35th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,420 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 11 | $1,439 |
| Risperidone | 38 | $1,273 |
| Mirtazapine | 26 | $1,095 |
| Sertraline Hcl | 42 | $604 |
| Lorazepam | 32 | $584 |
| Trazodone Hcl | 40 | $569 |
| Pregabalin | 18 | $460 |
| Clonazepam | 37 | $415 |
| Atorvastatin Calcium | 20 | $398 |
| Gabapentin | 26 | $345 |
| Pantoprazole Sodium | 17 | $341 |
| Alprazolam | 17 | $329 |
| Losartan Potassium | 21 | $303 |
| Donepezil Hcl | 17 | $302 |
Paid to pharmacies, not to this prescriber.
Other family in Lexington
- Amy LoperLexington$20K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.